Sofinnova Partners accepts Karl Nägler as a Partner

EQS News: Sofinnova Partners SAS / Schlagwort(e): Personality

Sofinnova Partners accepts Karl Nägler as a Partner

10.09.2024 / 09:00 CET/CEST
Inhaling the Mitteilung is the Issuer / Herausgeber responsible.

Sofinnova Partners accepts Karl Nägler as a Partner

Experienced Investor with 20 years of expertise and renewed investments in the financial position of venture capital funds in phased investments in Life Sciences

PARIS, France – September 10, 2024 — Sofinnova Partners (“Sofinnova”), a leading European Venture Capital Company in the Life Sciences field with locations in Paris, London and Milan, announces the appointment of Dr. Karl Nägler as Partner. This strategic personal development takes place within the expansion of Sofinnova in Germany and the expansion of the Reichsweite and the flow of companies in Europe.

Karl Nägler made a leap at Sofinnova Capital, the fresh investment strategy of his internal economies, which played a huge undertaking for 35 years. My expertise starts with the involvement of our colleagues, through phased innovation in the Bereich Life Sciences, and very much on a well-developed team of partners.

For the Tätigkeit at Sofinnova war Karl Nägler Managing Partner at Wellington Partners Life Sciences and Partner at Gimv. Where is much the success of several highly characterized start-ups assured – from the business development to the successful exit. Dazu founded Seamless Therapeutics, the company has established a top investor consortium, Breath Therapeutics, a co-investment with Sofinnova, from Zambon’s US company, Covagen, from Johnson & Johnson has acquired the company, Sowie Prosonix, from Circassia Pharmaceuticals’ US company.

“We will spend our time knowing and working with Karl and our future for ourselves,” says Graziano Seghezzi, Managing Partner at Sofinnova Partners. “His in-depth industry knowledge, his tadelloser Ruf and his narrow Beziehung of Sofinnova machine in one of the best positions for our team. Karls Ernennung follows the kürzliche Beförderung of Anta Gkelou by Principal zum Partner, where our Team of Senior Partner is further strengthened .”

“Sofinnova is a first-class company founded in the Venture Capital area for life sciences in Europe”, said Karl Nägler. “The opportunity, an investment platform that focuses on more sectors, phases and regions, and the team with such a high-quality team, could not do with more than a whole new weld. I can go ahead and use my experience in the construction and innovation of innovative life sciences companies throughout Europe and at the same time strengthen our presence in Germany.”

Karl Nägler’s career has acquired a strong position at Ventech and Atlas Venture. He has done a research on data erasure at the CNRS for Neurochemistry in Strasbourg and a PhD in Molecular Neurobiology at the Max-Delbrück-Zentrum for Molecular Medicine in Berlin.

###

About Sofinnova Partners

Sofinnova partners It is a European European company engaged in the development of life sciences in the Bereich, that is to say the Bereich Gesundheitsversorgung and a very special specialization. The company with seats in Paris, London and Mailland unites a team of professionals from all over the world with encompassing scientific, medical and industrial know-how. Sofinnova Partners is committed to being active in the development of research through investments in the Life Sciences Innovation Chain, from the initial phase to its intermediate growth phases. If one of the companies has set up a new company with a new company: as a leader of an investor, a fast-growing innovation, will have a positive potential effect on our common future have become.

Sofinnova Partners founded a company in 1972 and is a venture capital firm in Europe, which has lasted 50 years more than 500 years and built a market leader on the whole world. Aktuell verwaltet Sofinnova Partners for 2.8 billion euros. For more information about this information: www.sofinnovapartners.com

Contacts

Bommie Lee
Head of Communications
Sofinnova partners
[email protected]
+33 (0) 6 47 71 38 11

ROOF
MC Services AG
Katja Arnold, Kaja Skorka
[email protected]
+49-89-210 228-0

10.09.2024 CET/CEST Release of a Corporate News/Finanznachricht, übermittelt durch EQS News – a service of EQS Group AG.
Inhaling the Mitteilung is the Issuer / Herausgeber responsible.

The EQS Distribution Services include notifications, Corporate News/Finanznachrichten and Press Releases.
Media archive under https://eqs-news.com